Prolia
February 26, 2024
Alert! The FDA Issued Its Strictest Warning For Deadly Effects Of Osteoporosis Drug Prolia
The Food and Drug Administration (FDA) has added its strictest warning to Amgen’s osteoporosis drug Prolia (denosumab). The move comes after years of additional monitoring and testing of a known … Continue Reading →
April 7, 2012
Prolia Pros And Cons
At only 2 years out from FDA approval, Prolia (generic name, denosumab) is still considered a new treatment – so the pros and cons are still being weighed and considered … Continue Reading →
July 14, 2010
Prolia (Denosumab): My Review
This past June 1st, the FDA approved Prolia ™ (denosumab), a brand new twice-yearly injectable osteoporosis drug by Amgen. The first drug of its kind, Prolia was designed to treat … Continue Reading →
